Reported Apr 8, 2020 · Terminated
Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977,…
Par Pharmaceutical Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Par Pharmaceutical Inc. · 1 Ram Ridge Rd · Chestnut Ridge, NY · 10977-6714
Is this the product you have?
- Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist
- byPar Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg
- by
Par Formulations Private Limited1/58PudupakkamKelambakkam - 603 103Made in India NDC# 49884-0065-01
- Lot codes and dates
Lot # 32809101Exp 3/2021
- Amount recalled
- 29,352 bottles
Why it was recalled
Failed Impurities/Degradation Specification: Presence of unknown impurity observed.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Par Pharmaceutical Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.